Pirfenidone
Who holds supplier records for Pirfenidone? 31 organisations hold a current record for Pirfenidone: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 24 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (23), Italy (3), United Kingdom (1) and Spain (1); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Pirfenidone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/pirfenidone
Reading the evidence
- 31 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
23 of the 28 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 17 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Pirfenidone expires 28 Mar 2037. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (31)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Pirfenidone. Country is the organisation's recorded country, not necessarily the manufacturing site.
- HONOUR LAB LTDIndiaCEP Company GMP cert on recordActive DMF 40331, 29700 · latest filing Aug 2024
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 32772 · latest filing Jun 2018
- ALIVUS LIFE SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 31072 · latest filing Nov 2016
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 32696 · latest filing Apr 2018
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 32423 · latest filing Mar 2018
- COHANCE LIFESCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 32201 · latest filing Oct 2017
- Dipharma Francis SrlItalyCEP Company GMP cert on recordActive DMF 32224 · latest filing Apr 2018
- Granules India LimitedIndiaCEP Company GMP cert on recordActive DMF 30922 · latest filing Sept 2016
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 32384 · latest filing Jan 2018
- Laurus Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 32739 · latest filing May 2018
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 32657 · latest filing Apr 2018
- MICRO LABS LTDIndiaCEP Company GMP cert on recordActive DMF 32654 · latest filing Apr 2018
- MSN LIFE SCIENCES PRIVATE LIMITEDIndiaCEP Company GMP cert on recordActive DMF 31264 · latest filing Dec 2016
- OPTIMUS DRUGS PRIVATE LTDIndiaCEPActive DMF 32015 · latest filing Sept 2017
- PROCOS SPAItalyCEP Company GMP cert on recordActive DMF 31815 · latest filing Jul 2017
- SHILPA PHARMA LIFESCIENCES LTDIndiaCEPActive DMF 30952 · latest filing Sept 2016
- SMS Pharmaceuticals limitedIndiaCEP Company GMP cert on recordActive DMF 37925 · latest filing Dec 2022
- SNJ LABS PVT LTDIndiaCEPActive DMF 42640 · latest filing Sept 2025
- AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)IndiaActive DMF 33599 · latest filing Feb 2019
- CHEMECA DRUGS PRIVATE LTDIndiaActive DMF 40359 · latest filing Sept 2024
- CHEMO IBERICA SACEPActive DMF 32796 · latest filing May 2018
- Lupin LimitedIndia Company GMP cert on recordActive DMF 30351 · latest filing Apr 2016
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 31274 · latest filing Dec 2016
- RAKS PHARMA PVT LTDIndiaActive DMF 32304 · latest filing Dec 2017
- SIGNA SA DE CVActive DMF 15168 · latest filing Nov 2000
- VERANOVA LPUnited KingdomActive DMF 32680 · latest filing Mar 2018
- IndiaCEP
- ItalyCEP Company GMP cert on record
- LUPIN MANUFACTURING SOLUTIONS LTDCEP
- SpainCEP Company GMP cert on record
- IndiaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (24)
Certificates of Suitability on the EDQM register for Pirfenidone, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 28 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| CHEMO IBERICA S.A. Madrid | ES | CEP 2026-434 - Rev 00 Pirfenidone, MAHI Drugs site | Nov 2026 | — |
| PROCOS S.P.A. Cameri | IT | CEP 2020-073 - Rev 01 Pirfenidone | Oct 2026 | Inspected Oct 2025 Italy |
| DIPHARMA FRANCIS S.R.L. Baranzate | IT | CEP 2024-493 - Rev 00 Pirfenidone | Sept 2026 | Inspected Mar 2025 Italy |
| CAMBREX PROFARMACO MILANO S.R.L. Paullo | IT | CEP 2019-248 - Rev 01 Pirfenidone | Sept 2026 | Inspected Sept 2025 Italy |
| HONOUR LAB LIMITED Hyderabad | IN | CEP 2016-122 - Rev 01 Pirfenidone | Aug 2026 | — |
| GRANULES INDIA LIMITED Hyderabad | IN | CEP 2016-288 - Rev 03 Pirfenidone, Crystalline Form | May 2026 | — |
| ALIVUS LIFE SCIENCES LIMITED Mumbai | IN | CEP 2017-170 - Rev 05 Pirfenidone | May 2026 | — |
| SMS PHARMACEUTICALS LIMITED Hyderabad | IN | CEP 2024-559 - Rev 00 Pirfenidone | Apr 2026 | — |
| JUBILANT BIOSYS LIMITED Mysuru | IN | CEP 2018-091 - Rev 04 Pirfenidone | Jan 2026 | — |
| CIPLA LIMITED Mumbai | IN | CEP 2018-096 - Rev 01 Pirfenidone | Oct 2025 | — |
| MICRO LABS LIMITED Bengaluru | IN | CEP 2019-155 - Rev 02 Pirfenidone | Jun 2025 | — |
| ROLABO OUTSOURCING, S.L. Zaragoza | ES | CEP 2018-260 - Rev 01 Pirfenidone | May 2025 | Inspected Dec 2023 Spain |
| LAURUS LABS LIMITED Hyderabad | IN | CEP 2019-062 - Rev 02 Pirfenidone | May 2025 | — |
| OPTIMUS DRUGS PRIVATE LIMITED Hyderabad | IN | CEP 2018-007 - Rev 02 Pirfenidone | May 2025 | — |
| SNJ LABS PRIVATE LIMITED Dist. Rajkot | IN | CEP 2024-165 - Rev 00 Pirfenidone | May 2025 | — |
| AMOLI ORGANICS PRIVATE LIMITED Mumbai | IN | CEP 2019-067 - Rev 02 Pirfenidone | Apr 2025 | — |
| SHILPA PHARMA LIFESCIENCES LIMITED Raichur | IN | CEP 2016-242 - Rev 01 Pirfenidone, micronised, non-micronised | Apr 2025 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2018-147 - Rev 02 Pirfenidone | Feb 2025 | — |
| LUPIN MANUFACTURING SOLUTIONS LIMITED Mumbai | IN | CEP 2017-109 - Rev 04 Pirfenidone | Oct 2024 | — |
| COHANCE LIFESCIENCES LIMITED Mumbai | IN | CEP 2017-259 - Rev 03 Pirfenidone | Jul 2024 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2018-098 - Rev 03 Pirfenidone | Jun 2024 | — |
| MSN LIFE SCIENCES PRIVATE LIMITED Chandampet Village | IN | CEP 2017-103 - Rev 02 Pirfenidone, Crystalline form | Mar 2024 | Inspected Oct 2025 Slovakia |
| SHIVALIK RASAYAN LIMITED New Delhi | IN | CEP 2021-413 - Rev 00 Pirfenidone | Jan 2024 | — |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | R0-CEP 2021-077 - Rev 00 Pirfenidone | Jun 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (1)
Organisations whose Type II DMFs for Pirfenidone are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- Italy · Inactive DMF 5170 · filed Nov 1983
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (37 listed products contain Pirfenidone). The latest listed patent expires 28 Mar 2037. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Pirfenidone is a pyridine derivative with antifibrotic properties used to treat idiopathic pulmonary fibrosis by reducing lung fibrosis through modulation of the cytokine cascade. It is believed to exert its therapeutic effects by inhibiting TGF-beta and collagen synthesis and decreasing fibroblast proliferation.
Chemical identity
- IUPAC name
- 5-methyl-1-phenylpyridin-2-one
- Canonical SMILES
- CC1=CN(C(=O)C=C1)C2=CC=CC=C2
- InChIKey
- ISWRGOKTTBVCFA-UHFFFAOYSA-N
- Synonyms
- Esbriet API, amr-69, esbriet, esbriet component pirfenidone, nsc-748456, pirespa
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Pyridone
- Chemical structure
- Pyridones
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Pirfenidone?
31 organisations hold an active US FDA Type II Drug Master File or a CEP for Pirfenidone: HONOUR LAB LTD (India), Alembic Pharmaceuticals Limited (India), ALIVUS LIFE SCIENCES LTD (India), APITORIA PHARMA PRIVATE LTD (India), Cipla Limited (India), COHANCE LIFESCIENCES LTD (India), Dipharma Francis Srl (Italy) and Granules India Limited (India), and 23 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Pirfenidone Drug Master Files are active?
HONOUR LAB LTD (DMF 40331, 29700), Alembic Pharmaceuticals Limited (DMF 32772), ALIVUS LIFE SCIENCES LTD (DMF 31072), APITORIA PHARMA PRIVATE LTD (DMF 32696), Cipla Limited (DMF 32423), COHANCE LIFESCIENCES LTD (DMF 32201), Dipharma Francis Srl (DMF 32224) and Granules India Limited (DMF 30922) and 18 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Pirfenidone records mean?
1 organisation has only inactive Type II DMFs for Pirfenidone. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Pirfenidone have a European Certificate of Suitability?
Yes. 24 organisations hold a valid CEP for Pirfenidone on the EDQM register, including CHEMO IBERICA S.A. Madrid (ES), PROCOS S.P.A. Cameri (IT), DIPHARMA FRANCIS S.R.L. Baranzate (IT), CAMBREX PROFARMACO MILANO S.R.L. Paullo (IT), HONOUR LAB LIMITED Hyderabad (IN) and GRANULES INDIA LIMITED Hyderabad (IN) and 18 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Pirfenidone?
Yes. The latest patent listed for an approved US product containing Pirfenidone expires 28 Mar 2037, across 37 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Pirfenidone supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Pirfenidone?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.